Eliminative Signaling by Janus Kinases: Role in the Downregulation of Associated Receptors-Reference-Cited by-同舟云学术

Eliminative Signaling by Janus Kinases: Role in the Downregulation of Associated Receptors

Published:2013-11-14 Issue:1 Volume:115 Page:8-16
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Carbone Christopher J.¹,Fuchs Serge Y.¹

Affiliation:

1. Department of Animal Biology and Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine; University of Pennsylvania; Philadelphia Pennsylvania 19104

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcb.24647/fullpdf

Reference145 articles.

1. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells;Ammarguellat;Biochem Biophys Res Commun,2001

2. Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266;Anthes;Biochem J,1995

3. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation;Arcasoy;Exp Hematol,1999

4. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: Role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain;Arcasoy;Biochim Biophys Acta,2005

5. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor;Bhattacharya;J Biol Chem,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia;Cell Death & Disease;2024-05-28

2. Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors;eBioMedicine;2023-11

3. From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases;Frontiers in Genetics;2021-07-05

4. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia;Clinical and Translational Oncology;2021-05-04

5. A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon;Clinical Cancer Research;2016-09-28